Cargando…

Prostate cancer treated by anti-androgens: is sexual function preserved?

This paper reports on results of the EORTC protocol 30892, an open, prospective, randomized study of 310 patients with previously untreated metastatic prostate cancer with favourable prognostic factors who were treated by either flutamide (FLU) or cyproterone acetate (CPA) monotherapy. The final ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schröder, F H, Collette, L, Reijke, T M de, Whelan, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363280/ https://www.ncbi.nlm.nih.gov/pubmed/10646878 http://dx.doi.org/10.1054/bjoc.1999.0916

Ejemplares similares

Regulation of expression of Na(+),K(+)-ATPase in androgen-dependent and androgen-independent prostate cancer
por: Blok, L J, et al.
Publicado: (1999)

Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis
por: Costa-Pereira, A P, et al.
Publicado: (1999)

Sexual behaviour, STDs and risks for prostate cancer
por: Hayes, R B, et al.
Publicado: (2000)

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
por: Bratt, O, et al.
Publicado: (1999)

Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer
por: Sidiropoulos, M, et al.
Publicado: (2001)

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells
por: Cronauer, M V, et al.
Publicado: (2000)

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
por: Oh, Su Jung, et al.
Publicado: (2012)

Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis
por: Costa-Pereira, A P, et al.
Publicado: (2000)

mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer
por: Schiewer, Matthew J, et al.
Publicado: (2012)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
por: Abd. Wahab, Nurul Azwa, et al.
Publicado: (2020)

Anti-androgenic effects of flavonols in prostate cancer
por: Boam, Tristan
Publicado: (2015)

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
por: Dart, D Alwyn, et al.
Publicado: (2009)

Optimal timing and dosage of chemotherapy as a combined treatment with androgen withdrawal in the human prostate LNCaP tumour model
por: Miyake, H, et al.
Publicado: (2001)

A study of the prostate, androgens and sexual activity of male rats
por: Hernandez, Maria Elena, et al.
Publicado: (2007)

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
por: Culig, Z, et al.
Publicado: (1999)

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
por: Collette, Fanny, et al.
Publicado: (2020)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Long-term effects on sexual function and fertility after treatment of testicular cancer
por: Hartmann, J T, et al.
Publicado: (1999)

Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy
por: Siddiqui, Zaid A., et al.
Publicado: (2018)

RNA sequencing data of human prostate cancer cells treated with androgens
por: Poluri, Raghavendra Tejo Karthik, et al.
Publicado: (2019)

Impact of anabolic androgenic steroids on sexual function
por: Armstrong, Joseph Matthew, et al.
Publicado: (2018)

Androgen receptor functions in prostate cancer development and progression
por: Balk, Steven P
Publicado: (2014)

The epigenetic function of androgen receptor in prostate cancer progression
por: Sawada, Takahiro, et al.
Publicado: (2023)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
por: Handle, Florian, et al.
Publicado: (2019)

Macrophages promote anti-androgen resistance in prostate cancer bone disease
por: Li, Xue-Feng, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture
por: Eder, Theresa, et al.
Publicado: (2016)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
por: Zhang, Li, et al.
Publicado: (2016)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
por: Lallous, Nada, et al.
Publicado: (2016)

Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen
por: Takeda, Keisuke, et al.
Publicado: (2016)

Prostate Cancer and Sexual Function
por: Hyun, Jae Saog
Publicado: (2012)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
por: Rajan, Prabhakar, et al.
Publicado: (2014)

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
por: Lallous, Nada, et al.
Publicado: (2013)

Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
por: Eom, Keun-Yong, et al.
Publicado: (2014)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
por: Li, Weina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84easq22s3j9nt2agtk9i36j5s